Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids

MJBizDaily
By Lisa Bernard-KuhnSep 5, 2018, 4:03 pm93 pts
Canadian cannabis producer Cronos Group has tapped Boston-based Ginkgo Bioworks in a $122 million endeavor to biologically engineer a wide range of cannabinoids found in cannabis. Under the deal, announced Tuesday, Ginkgo, which creates customized microbes, will work exclusively with Cronos to research and…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

30 cannabis vapes set to launch in Quebec by late November 79

iAnthus Expands Florida Footprint With GrowHealthy Dispensary Opening in Tamarac 74

Trump Administration To Issue Warnings About Marijuana’s Impact On Youth Under Plan Led By RFK Jr. 71

New Hampshire Lawmakers To Move Forward With Marijuana Legalization Bill Despite Governor’s Opposition 68

Texas Hemp Business Council Supports Protections for Minors 60

Webinar Replay | Cannabis Without Borders 59

House GOP Moves Forward on Blocking Trump Administration’s Power to Reschedule Cannabis 48

The Canadian Listing Does Not Matter for American Cannabis Companies 45

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.